The multisystem adverse effects of NSAID therapy

Area of Science:

• Pharmacology
• Gastroenterology
• Drug Safety

Background:

• Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for pain and inflammation.
• Their clinical utility is limited by significant adverse side effects, particularly gastrointestinal (GI) toxicity.
• These side effects stem from the non-specific inhibition of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2).

Purpose of the Study:

• To review the adverse effects of NSAIDs, focusing on gastrointestinal complications.
• To highlight the importance of identifying at-risk patients and managing NSAID-induced GI events.
• To discuss the potential of COX-2 specific inhibitors in mitigating NSAID-associated toxicities.

Main Methods:

• Literature review on NSAID pharmacology and clinical outcomes.
• Analysis of mechanisms underlying NSAID-induced GI damage.
• Evaluation of the safety profile of COX-2 selective inhibitors compared to non-selective NSAIDs.

Main Results:

• NSAIDs inhibit both COX-1 and COX-2, leading to upper GI ulceration, perforation, and bleeding.
• These GI events can be severe, asymptomatic, and occur with little warning.
• Clinicians must be vigilant in risk assessment and management of NSAID-induced GI adverse events.

Conclusions:

• The non-specific inhibition of COX enzymes by NSAIDs is directly linked to serious GI toxicity.
• Awareness and proactive management are crucial for patients on NSAID therapy.
• Selective COX-2 inhibitors represent a potentially safer alternative for pain and inflammation management, minimizing GI risks.